{
  "title": "Bloomberg Markets: Gilead to Buy Kite for $11.9 Billion",
  "itunes:title": "Bloomberg Markets: Gilead to Buy Kite for $11.9 Billion",
  "description": "<p>(Bloomberg) -- Bloomberg Markets with Carol Massar and Cory Johnson.\n\nGUEST:\nAsthika Goonewardene\nSenior Analyst:Biotech\nBloomberg Intelligence\nDiscussing Gilead Sciences Inc. agreed to buy Kite Pharma Inc. for about $11.9 billion, making one of its biggest deals ever to expand beyond its eroding hepatitis C drug franchise. </p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "content:encoded": "<p>(Bloomberg) -- Bloomberg Markets with Carol Massar and Cory Johnson.\n\nGUEST:\nAsthika Goonewardene\nSenior Analyst:Biotech\nBloomberg Intelligence\nDiscussing Gilead Sciences Inc. agreed to buy Kite Pharma Inc. for about $11.9 billion, making one of its biggest deals ever to expand beyond its eroding hepatitis C drug franchise. </p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "itunes:summary": "Bloomberg Markets: Gilead to Buy Kite for $11.9 Billion",
  "itunes:episodeType": "full",
  "itunes:author": "Bloomberg",
  "itunes:image": "",
  "media:content": [
    {
      "media:player": ""
    },
    ""
  ],
  "guid": "https://assets.bwbx.io/av/users/iqjWHBFdfxIU/vBvwqFueKjf0/v2.mp3",
  "omny:clipId": "a7389a12-8e86-4169-989c-ae2b00e2bfb6",
  "pubDate": "Mon, 28 Aug 2017 19:50:56 +0000",
  "itunes:duration": 615,
  "enclosure": "",
  "link": "https://omny.fm/shows/bloomberg-businessweek/bloomberg-markets-gilead-to-buy-kite-for-11-9-bill"
}